NCT00243243View on ClinicalTrials.gov

Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions
Burns
Interventions
DRUG

Recombinant Factor VIIa

intravenous infusion of Factor VIIa

DRUG

Placebo

intravenous infusion of placebo (sterile water)

Trial Locations (1)

78234

United States Army Institute of Surgical Research, Fort Sam Houston

All Listed Sponsors
lead

United States Army Institute of Surgical Research

FED

NCT00243243 - Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major Burn | Biotech Hunter | Biotech Hunter